Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISE Adult Medication Study
NCT01779362Phase 3Completed
- Sponsor
- RISE Study Group
- Start
- Apr 2013
- Primary completion
- Feb 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide, insulin glargine in prediabetes, type 2 diabetes mellitus (T2DM), sponsored by RISE Study Group. Started Apr 2013; status: completed.
02
Drugs
liraglutideinsulin glargine
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01779362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779362.